Aspire Biopharma Holdings reported a gross margin of -47.68% and a net margin of -2,009.61% for the quarter ended Jun 2026. These financial ratios cover 19 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||
| Gross Margin | 45.54% | -23.47% | 20.28% | -47.68% | |||||||||||||||
| EBT Margin | -135,268.16% | -189,692.96% | -11,367.02% | -2,009.61% | |||||||||||||||
| EBIT Margin | -59,015.82% | -43,403.52% | -5,805.98% | -4,244.14% | |||||||||||||||
| EBITDA Margin | -59,015.82% | -43,403.52% | -5,805.98% | -4,244.14% | |||||||||||||||
| Operating Margin | -59,015.82% | -43,403.52% | -5,805.98% | -4,244.14% | |||||||||||||||
| Net Margin | -135,268.16% | -189,692.96% | -11,367.02% | -2,009.61% | |||||||||||||||
| FCF Margin | -56,868.06% | -21,775.19% | -10,716.76% | -3,352.68% | |||||||||||||||
| Efficiency | |||||||||||||||||||
| Inventory AverageInventory Avg. | 0.14M | 0.31M | 0.33M | ||||||||||||||||
| Assets AverageAssets Avg. | 148.40M | 296.61M | 297.28M | 299.01M | 301.64M | 161.84M | 20.23M | 19.94M | 20.09M | 13.53M | 1.06M | 1.48M | 1.70M | 1.86M | 4.21M | 10.33M | |||
| Invested CapitalInvested Cap. | 0.24M | -0.10M | -0.06M | 4.80M | 5.07M | 13.99M | -3.57M | -4.67M | -3.17M | -3.34M | 4.37M | 11.76M | |||||||
| Asset Utilization RatioAsset Util. | 0.01 | ||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||
| Interest Coverage RatioInterest Cover | -53.66 | -1.52 | -0.77 | -0.30 | -1.03 | ||||||||||||||
| Debt Ratio | 0.81 | 0.02 | 0.02 | 0.78 | 104.92 | 2.23 | 5.00 | 3.45 | 2.32 | 0.07 | |||||||||
| Times Interest Earned | -53.66 | -1.52 | -0.77 | -0.30 | -1.03 | ||||||||||||||
| Return Ratios | |||||||||||||||||||
| Return on Sales [ROS]ROS | -59,015.82% | -43,403.52% | -5,805.98% | -4,244.14% | |||||||||||||||
| Return on Capital Employed [ROCE]ROCE | 189.87% | 149.37% | 337.41% | -512.23% | -84.69% | ||||||||||||||
| Return on Assets [ROA]ROA | -1,272.89% | -1,250.73% | -1,541.25% | -377.55% | -147.15% |